These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28891816)

  • 1. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer.
    Caino MC; Seo JH; Wang Y; Rivadeneira DB; Gabrilovich DI; Kim ET; Weeraratna AT; Languino LR; Altieri DC
    J Clin Invest; 2017 Oct; 127(10):3755-3769. PubMed ID: 28891816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements.
    Seo JH; Agarwal E; Bryant KG; Caino MC; Kim ET; Kossenkov AV; Tang HY; Languino LR; Gabrilovich DI; Cohen AR; Speicher DW; Altieri DC
    Cancer Res; 2018 Aug; 78(15):4215-4228. PubMed ID: 29898993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neuronal network of mitochondrial dynamics regulates metastasis.
    Caino MC; Seo JH; Aguinaldo A; Wait E; Bryant KG; Kossenkov AV; Hayden JE; Vaira V; Morotti A; Ferrero S; Bosari S; Gabrilovich DI; Languino LR; Cohen AR; Altieri DC
    Nat Commun; 2016 Dec; 7():13730. PubMed ID: 27991488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation.
    Kang JS; Tian JH; Pan PY; Zald P; Li C; Deng C; Sheng ZH
    Cell; 2008 Jan; 132(1):137-48. PubMed ID: 18191227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted-in-schizophrenia 1 (DISC1) and Syntaphilin collaborate to modulate axonal mitochondrial anchoring.
    Park C; Lee SA; Hong JH; Suh Y; Park SJ; Suh BK; Woo Y; Choi J; Huh JW; Kim YM; Park SK
    Mol Brain; 2016 Jul; 9(1):69. PubMed ID: 27370822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynein light chain LC8 regulates syntaphilin-mediated mitochondrial docking in axons.
    Chen YM; Gerwin C; Sheng ZH
    J Neurosci; 2009 Jul; 29(30):9429-38. PubMed ID: 19641106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Releasing Syntaphilin Removes Stressed Mitochondria from Axons Independent of Mitophagy under Pathophysiological Conditions.
    Lin MY; Cheng XT; Tammineni P; Xie Y; Zhou B; Cai Q; Sheng ZH
    Neuron; 2017 May; 94(3):595-610.e6. PubMed ID: 28472658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syntaphilin downregulation facilitates radioresistance via mediating mitochondria distribution in esophageal squamous cell carcinoma.
    Chen X; Xu W; Zhuo S; Chen X; Chen P; Guan S; Huang D; Sun X; Cheng Y
    Free Radic Biol Med; 2021 Mar; 165():348-359. PubMed ID: 33577962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport.
    Chen Y; Sheng ZH
    J Cell Biol; 2013 Jul; 202(2):351-64. PubMed ID: 23857772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor.
    Hwang MJ; Bryant KG; Seo JH; Liu Q; Humphrey PA; Melnick MAC; Altieri DC; Robert ME
    Am J Pathol; 2019 Jun; 189(6):1180-1189. PubMed ID: 31079810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Removing dysfunctional mitochondria from axons independent of mitophagy under pathophysiological conditions.
    Lin MY; Cheng XT; Xie Y; Cai Q; Sheng ZH
    Autophagy; 2017 Oct; 13(10):1792-1794. PubMed ID: 28812939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitophagy effector FUNDC1 controls mitochondrial reprogramming and cellular plasticity in cancer cells.
    Li J; Agarwal E; Bertolini I; Seo JH; Caino MC; Ghosh JC; Kossenkov AV; Liu Q; Tang HY; Goldman AR; Languino LR; Speicher DW; Altieri DC
    Sci Signal; 2020 Jul; 13(642):. PubMed ID: 32723812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion.
    Rivadeneira DB; Caino MC; Seo JH; Angelin A; Wallace DC; Languino LR; Altieri DC
    Sci Signal; 2015 Aug; 8(389):ra80. PubMed ID: 26268608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntaphilin mediates axonal growth and synaptic changes through regulation of mitochondrial transport: a potential pharmacological target for neurodegenerative diseases.
    Wu QY; Liu HL; Wang HY; Hu KB; Liao P; Li S; Long ZY; Lu XM; Wang YT
    J Drug Target; 2023 Aug; 31(7):685-692. PubMed ID: 37358358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate Intrusion of an Axonal Mitochondrial Anchor into Dendrites Causes Neurodegeneration.
    Joshi DC; Zhang CL; Babujee L; Vevea JD; August BK; Sheng ZH; Chapman ER; Gomez TM; Chiu SY
    Cell Rep; 2019 Oct; 29(3):685-696.e5. PubMed ID: 31618636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of mitochondrial anchoring protects dysmyelinating shiverer: implications for progressive MS.
    Joshi DC; Zhang CL; Lin TM; Gusain A; Harris MG; Tree E; Yin Y; Wu C; Sheng ZH; Dempsey RJ; Fabry Z; Chiu SY
    J Neurosci; 2015 Apr; 35(13):5293-306. PubMed ID: 25834054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntaphilin Inactivation Can Enhance Axonal Mitochondrial Transport to Improve Spinal Cord Injury.
    Lu Q; Zhang Y; Botchway BOA; Huang M; Liu X
    Mol Neurobiol; 2023 Nov; 60(11):6556-6565. PubMed ID: 37458986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis.
    Seo JH; Rivadeneira DB; Caino MC; Chae YC; Speicher DW; Tang HY; Vaira V; Bosari S; Palleschi A; Rampini P; Kossenkov AV; Languino LR; Altieri DC
    PLoS Biol; 2016 Jul; 14(7):e1002507. PubMed ID: 27389535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syntaphilin Regulates Neutrophil Migration in Cancer.
    Fu S; Deng H; Bertolini I; Perego M; Chen ES; Sanseviero E; Mostafa A; Alicea-Torres K; Garcia-Gerique L; Stone EL; Kossenkov AV; Schug ZT; Nam B; Mulligan C; Altieri DC; Nefedova Y; Gabrilovich DI
    Cancer Immunol Res; 2023 Mar; 11(3):278-289. PubMed ID: 36548516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
    Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
    Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.